A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions
Completed · Phase 2 · Has a placebo group
Conditions studied: Pleural Effusion
In brief
The LTI-01-2001 study is a double-blind, placebo-controlled, Phase 2 study to evaluate LTI-01 (single-chain urokinase plasminogen activator, scuPA) in patients with infected, non-draining pleural effusions.
Key facts
- Study ID
- NCT04159831
- Run by
- Rein Therapeutics
- People needed
- 44
- Starts
- 2020-09-26
- Expected to finish
- 2022-07-28
- Last updated by the study team
- 2023-03-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The University of Alabama at Birmingham — Birmingham, Alabama, United States
- UC San Diego Health Jacobs Medical Center — La Jolla, California, United States
- University of California (UCLA) — Los Angeles, California, United States
- UC Davis Medical Group — Sacramento, California, United States
- University of Colorado — Aurora, Colorado, United States
- Yale School of Medicine — New Haven, Connecticut, United States
- Rush University Medical Center — Chicago, Illinois, United States
- The University of Kansas Medical Center — Kansas City, Kansas, United States
- University of Maryland School of Medicine — Baltimore, Maryland, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Lahey Hospital and Medical Center — Burlington, Massachusetts, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Mayo Clinic — Rochester, Minnesota, United States
- University of Mississippi Medical Center — Jackson, Mississippi, United States
- St. Luke's Health System — Kansas City, Missouri, United States
- Washington University — St Louis, Missouri, United States
- CHI CUMC Bergan Mercy — Omaha, Nebraska, United States
- North Shore - Long Island Jewish Medical Center — Queens, New York, United States
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
- Duke University — Durham, North Carolina, United States
- The Ohio State University — Columbus, Ohio, United States
- The Pennsylvania State University — Hershey, Pennsylvania, United States
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.